Citius Oncology (CTOR) Inventory Average (2024 - 2026)

Citius Oncology (CTOR) has 3 years of Inventory Average data on file, last reported at $22.6 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 52.42% year-over-year to $22.6 million in Q1 2026; TTM through Mar 2026 was $22.6 million, a 52.42% increase from a year earlier, with the FY2025 full-year figure at $15.3 million, changed N/A from the prior year.
• Inventory Average for Q1 2026 stood at $22.6 million, up from $22.5 million in the prior quarter.
• Over the last five years, Inventory Average for CTOR reached as high as $22.6 million in Q1 2026 and fell as low as $11.3 million in Q4 2024.
• Historically, Inventory Average has averaged $17.9 million across 3 years, with a median of $18.0 million in 2025.
• Across the five-year window, Inventory Average surged 98.35% in 2025 and surged 52.42% in 2026, its largest moves.
• Year by year, Inventory Average stood at $11.3 million in 2024, then jumped by 98.35% to $22.5 million in 2025, then gained by 0.83% to $22.6 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $22.6 million in Q1 2026, $22.5 million in Q4 2025, and $19.7 million in Q3 2025.